Femara (letrozole) to prevent recurrent breast cancer
November 2003
You'll see more women taking Femara (letrozole) to prevent recurrent breast cancer.
Tamoxifen is the standard of care for hormone-receptor-positive breast cancer. Taking it for 5 years reduces the risk of recurrence by 47% and improves survival.
But after 5 years tamoxifen's benefits wane.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote